Now Available On-Demand!
Join the industry’s first fully virtual meeting on decentralized clinical trials

About:


Following on the success of ExL’s Virtual Clinical Trial conference last year, we wanted to continue the conversation and invite our community to discuss decentralized clinical trials in an online forum.

This virtual event will bring together industry experts to discuss the increasing pace of pharmaceutical innovation, the need to maintain data quality and integrity as new technologies are implemented and understand regulatory challenges to ensure compliance.

Agenda

Wednesday, April 22 (All times in ET)


10:00am-10:15am | Conference Chairs’ Opening Remarks
10:15am-10:45am | What is COVID-19 Teaching us about optimal Clinical Trial Conduct Right Now?
10:45am-11:30am | Decentralized Clinical Trials (DCT) in the Time of COVID-19 and Beyond
11:30am-11:45am | Networking Break
11:45am-12:45pm | Multi-Stakeholder Perspective on Virtual Clinical Trials
12:45pm-1:30pm | Kickoff in a Crisis: Lessons from Launching the First Fully Virtual Trial During a Pandemic  
1:30pm-1:45pm | Chairperson’s Closing Remarks

Thursday, April 23 (All times in ET)



10:15am-10:45am | Understanding Regulatory Challenges and Ensure Compliance
10:45AM-11:30AM | Accelerating Clinical Trials and Processes with Emerging Technologies
11:30AM-11:45AM | Networking Break
11:45AM-12:45PM | Panel Discussion: Leveraging Technology to Drive Direct-to-Patient Trial Designs 
12:45PM-1:15PM | Maintaining Data Consistency: Traditional to Virtual Trial Continuum 

Featured Speakers:

Mohammed Ali

Global Head Digital Development, Global Clinical Operations
Boehringer Ingelheim

Brad Davidsen

Counsel, Clinical R&D
AbbVie

Adama Ibrahim, EMBA

Associate Director, Performance Operational Capabilities, Global Clinical Operations
Biogen

Alka Shaunik, M.D.

Senior Medical Director, Global Medical Affairs
Sanofi

Kirsten Engelhardt MA, MBA

Associate Director, Applied Innovation & Process Improvement
Otsuka Pharmaceutical Companies (U.S.)

Jennifer Goldsack, MChem, MA, MBA

Executive Director
Digital Medicine Society (DiMe)

Rob Scott, M.D.

Chief Medical Officer, Head of Development
AbbVie
Now Available On-Demand!